Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical Donor HCT for Severe Aplastic Anemia
NCT04558736Phase 2Recruiting
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Jan 2021
- Primary completion
- Jul 2029
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of HPC-A, CD45RA depleted donor lymphocyte infusion in aplastic anemia, sponsored by St. Jude Children's Research Hospital. Started Jan 2021; status: recruiting.
02
Drugs
HPC-ACD45RA depleted donor lymphocyte infusion
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT04558736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04558736.